Navigation Links
Now, Silica Nanobubbles for Targeted Drug Delivery

Indian researchers at the Indian Institute of Technology (IIT), Chennai, have succeeded in entrapping antibiotics within silica nanobubbles and delivering them into cells, a// major step towards drug efficacy.

The researchers have used the 'Core-shell system' that comprises a core of one material and a shell of another (inert) material.

The possibility of delivering therapeutic molecules into cells and monitoring it through fluorescence imaging has opened up new possibilities, claims Thalappil Pradeep, who led the team at IIT.

They incorporated ciprofloxacin (a known antibiotic) molecules on the gold nanoparticle surface with subsequent growth of a silica shell over that. This was followed by removal of the gold core -- using a method they have patented -- leaving behind a "nanobubble" inside which the antibiotic was trapped.

"A hollow nanobubble or nanoshell of silica (10-20 nm in diameter, 1-2 nm shell thickness) contains about 65 molecules of ciprofloxacin," Pradeep told IANS. (Human hair by comparison is 100,000 nanometres thick).

He said that they used sophisticated techniques like "fluorescence anisotropy" to show that the molecules are confined within the cage.

The advantage of such nanoscopic containers is they provide a rigid environment for the trapped molecules protecting them from unwanted chemical reactions, said Pradeep.

Though core-shell systems are known, "what is new in our work is the entrapment of antibiotics within nanoceramic shells and their delivery into cells", he said. The drug-loaded nanobubbles are stable and can be stored for extended periods.

In actual experiments, Pradeep and his colleagues incubated the shells containing the antibiotic (or a fluorescence label) with E. coli bacteria and observed the distribution of the drug inside the bacterium by fluorescence imaging technique.

In this work, the shells were not made specific to the cells, Pradeep explained. But that is possible by attaching appropriate antibodies to the nanobubbles that would allow them to 'home in' on target cells.

The work of Pradeep and fellow researchers is to appear in the prestigious journal 'Langmuir'.

"As the porosity of the shells is controllable, controlled release of drugs can be achieved," they said. "Furthermore, stability, ease of synthesis and bio-compatibility of silica shells make this system a better choice in comparison to other chemical analogues."

Source-IANS
'"/>




Related medicine news :

1. Gel Offers A More Targeted Approach
2. New Vaccine Targeted At Effective Treatment Against Tuberculosis
3. Doctors, Pharma Companies Targeted By CBI Raids
4. Treatment Resistant Tumors Can Be Targeted Better Using Botox
5. KFC Targeted in Lawsuit
6. Targeted Anesthesia Can Minimize Pain During Prostate Biopsy
7. Targeted Compound Helps Recurrent Prostate Cancer Patients
8. Tumors Targeted Naturally
9. New Mechanism Identified for Resistance to Targeted Lung Cancer Drugs
10. Laboratory Testing Can Identify Risk of Pre-Term Labor and Delivery
11. Link between C-section Delivery and Stillbirth
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/25/2017)... ... July 25, 2017 , ... SureVest Insurance Group, a ... communities across North Carolina, is launching a charity event in conjunction with the ... the ongoing fight against bladder cancer. , The Bladder Cancer Advocacy Network (BCAN) ...
(Date:7/25/2017)... ... July 25, 2017 , ... Dr. Donna Bergman, professor of ... and published an article in the medical science journal Physical Medicine and Rehabilitation ... article and the research that helped produce it, were written and conducted in ...
(Date:7/25/2017)... WI (PRWEB) , ... July 25, 2017 , ... ... Aloria Health, as medical director. Dr. Negrette has more than a decade of ... She has worked closely with individuals fighting addictions, eating disorders, psychotic and manic ...
(Date:7/25/2017)... ... July 25, 2017 , ... ... Product Innovation in the prestigious CEO World Awards®. The coveted annual CEO World ... and services, CEO case studies, corporate social responsibility, and milestones from every major ...
(Date:7/24/2017)... PARK (PRWEB) , ... July 24, 2017 , ... Engineers ... is bio-compatible, because it produces the same kind of electrical energy that the body ... the form of moving electrons. This flow of electrons out of the battery is ...
Breaking Medicine News(10 mins):
(Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston ... and unparalleled access to global decision makers and innovative ... 800+ life science leaders during two impactful days. BioPharm ... provides delegates with additional networking opportunities with 4,500+ life ...
(Date:7/5/2017)... 5, 2017 Oramed Pharmaceuticals Inc. ... ), a clinical-stage pharmaceutical company focused on the development ... received approval from the Israel Securities Authority to dual-list its ... common stock will commence trading on the TASE on July ... market capitalization of the Company, it is expected that Oramed ...
Breaking Medicine Technology: